# Antiandrogen Therapy With or Without Axitinib Before Surgery in Treating Patients With Previously Untreated Prostate Cancer With Known or Suspected Lymph Node Metastasis

> **NCT01409200** · PHASE2 · COMPLETED · sponsor: **M.D. Anderson Cancer Center** · enrollment: 73 (actual)

## Conditions studied

- Metastatic Malignant Neoplasm in Lymph Node
- Prostate Ductal Adenocarcinoma
- Stage III Prostate Adenocarcinoma AJCC v7
- Stage IV Prostate Adenocarcinoma AJCC v7

## Interventions

- **DRUG:** Antiandrogen Therapy
- **DRUG:** Axitinib
- **PROCEDURE:** Radical Prostatectomy
- **PROCEDURE:** Regional Lymph Node Dissection

## Key facts

- **NCT ID:** NCT01409200
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-03-26
- **Primary completion:** 2026-02-05
- **Final completion:** 2026-02-05
- **Target enrollment:** 73 (ACTUAL)
- **Last updated:** 2026-03-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01409200

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01409200, "Antiandrogen Therapy With or Without Axitinib Before Surgery in Treating Patients With Previously Untreated Prostate Cancer With Known or Suspected Lymph Node Metastasis". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT01409200. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*